医療用バイオバンキング市場(2014-2024)...市場調査レポートについてご紹介

【英文タイトル】Biobanking for Medicine: Technology, Industry and Market 2014-2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Executive Summary
1.1 What Does This Report Cover?
1.1.1 The Human Tissue Banking Market – Our Definition
1.1.2 The Stem Cell Banking Market – Our Breakdown
1.2 Biobanking for Medicine: Technology, Industry and Market 2014-2024 Overview
1.3 Chapter Outlines
1.4 Speculative Aspects of Assessing the Biobanking Market
1.5 Research and Analysis Methods
1.6 Glossary of Terms in this Report
2. Introduction to Biobanking and its Applications
2.1 What is Biobanking?
2.2 Main Features of Biobanks
2.3 What Processes are Involved in Biobanking?
2.4 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.4.1 Volunteer Group: Population- vs. Disease-Based
2.4.2 Ownership Structure: Public vs. Private
2.5 The Guidelines and Standards for Biobanking
2.6 Laws and Regulations for Biobank-Based Research
2.6.1 HIPAA Amendments
2.7 Biobanking and the Pharmaceutical Industry
2.7.1 Biobanking in Research, Drug Discovery and Development
2.7.1.1 Understanding Disease Pathways
2.7.1.2 Drug Discovery
2.7.1.3 Biomarker Discovery in Drug Development
2.7.2 Biobanking for Therapeutics
2.7.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2014-2024
3.1 The World Biobanking for Medicine Market in 2013
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2018 and 2024
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2014-2024
3.4 Biobanks Stored Almost 1.3 Billion Specimens in 2013, and That Figure Increases
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2014-2024
3.6 Biobanking for Research: A $10bn Industry
3.6.1 Biobanking for Research: Revenue Forecast 2014-2024
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: A Worthwhile Endeavour or a Waste of Money?
3.7.1 Arguments Against Commercial Stem Cell Banking for Therapeutic Purposes
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2014-2024
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Use, 2014-2024
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2013
4.2 Biobanking for Research in 2018 and 2024: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2014-2024
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2013
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2014-2024
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2014-2024
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2014-2024
4.8 The Stem Cell Banking Market for Research in 2013
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2014-2024
4.9.1 A Shift in R&D Towards Stem Cells
4.10 Banking of Other Biologic Specimens for Research in 2013
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2014-2024
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2013: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2018 and 2024
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: A Grouped Revenue Forecast
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2013
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2014-2024
5.7 The Adult Stem Cell Banking Market in 2013
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2014-2024
6. Leading National Markets 2014-2024
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Rapidly Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2013
6.3 The Leading National Markets: A Grouped Revenue Forecast 2014-2024
6.4 How Will Regional Market Shares Change to 2024?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Leading European Biobanking Markets 2014-2024: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: 215 Biobanks Were Licensed Under the HTA in 2013
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2014-2024: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share Between 2014 and 2024
6.8.1 The Chinese Biobanking Market 2014-2024: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2014-2024: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2014-2024: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2014-2024?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquotting: Patented Technology From CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: The Most Important Component of Biobanking?
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy- Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2013
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services From Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2014-2024
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2014-2024
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2014-2024
10. Research Interviews from Our Survey
10.1 Interview with Dr Kirstin Goldring, Biobank and BioResource Coordinator, University College London, UK
10.1.1 On the Size of the UCL Biobank and How its Growing
10.1.2 On Users of UCL Biobank
10.1.3 On the Increasing Demand for Biobanked Samples
10.1.4 On Technology Used at UCL Biobank
10.1.5 On the Cost of Access to Samples
10.1.6 Concerns, Challenges and Restraining Factors
10.1.7 The Future of Biobanking
10.2 Interview With Dr Husein Salem, Chief Executive Officer, Precious Cells BioBank, London
10.2.1 On the Increasing Demand for Stem Cell Banking Services
10.2.2 On Novel Stem Cell Therapies in Development
10.2.3 Storage of Adult Stem Cells vs. Storage of Umbilical Cord Blood
10.2.4 On the Demand for Stem Cell Banking in Different Countries
10.2.5 On Challenges in the Industry
10.2.6 On Technology Used at Precious Cells
10.2.7 On Unmet Needs in the Stem Cell Banking Industry
10.2.8 On the Future of Stem Cell Banking
10.3 Interview with Dr David Bunton, CEO and Co-Founder, Biopta Ltd.
10.3.1 One the Use of Human Tissue Samples by Biopharmaceutical Companies
10.3.2 Human Tissue vs. Stem Cells
10.3.3 On the Technology Used in Biobanks
10.3.4 On the Future of the Biobanking Market
10.4 Interview with Dr Michael Leek, Commercial Operations Director, Pharmacells
10.4.1 On the Recent Increase in Stem Cell Banking Activity
10.4.2 On the Services of Pharmacells
10.4.3 On Adult Stem Cell Banking vs. Umbilical Cord Blood Banking
10.4.4 On Challenges Facing the Stem Cell Banking Market
10.4.5 On the Technology Used by Pharmacells
10.4.6 On the Future of the Market
10.5 Interview with Dr Tetsuro Wakatsuki, Chief Scientific Officer, InvivoSciences Inc.
10.5.1 On the Services Provided by InvivoSciences
10.5.2 On the Future of this Biobanking-Associated Market
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2014-2024: High Revenue Growth Predicted
11.2 Biobanking for Research 2014-2024: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2014-2024: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples Means Increasing Revenue
11.5.2 Improving Biobanking Infrastructure Engenders Growth
11.5.3 Marked Challenges, but Opportunities for Expansion


【レポート販売概要】

■ タイトル:医療用バイオバンキング市場(2014-2024)
■ 英文:Biobanking for Medicine: Technology, Industry and Market 2014-2024
■ 発行日:2014年3月
■ 調査会社:visiongain
■ 商品コード:Visiongain-4052639
■ 調査対象地域:グローバル
  • Genital Herpes:グローバル臨床試験レビューH1, 2013
    Genital Herpes Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per …
  • 3Dスキャナーの世界市場:レーザー式3Dスキャナー、構造化光式3Dスキャナー
    3D scanners capture and measure geometry of physical object or environment by using lasers or structured light. Data captured by these 3D scanners are often called as point clouds, which are used by software to create 3D representation of the scanned object or physical environment for in-depth analysis, inspection, and modification. 3D scanners find wide application across several industries to en …
  • 感情分析の世界市場予測(~2024年)
    Global emotion analytics market size to grow at a CAGR of 15.8% during the forecast period The global emotion analytics market size to grow from USD 2.2 billion in 2019 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 15.8% during 2019–2024. Need for higher customer satisfaction, rising significance for real-time emotion analytics, adherence to regulatory and compliance stand …
  • 世界の補聴器市場動向(2012-2016)
    TechNavio's analysts forecast the Global Hearing Aids market to grow at a CAGR of 7.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing sale of digital hearing aid devices. The Global Hearing Aids market has also been witnessing an increased number of mergers and acquisitions. However, issues with the hearing aid batteries could pose a …
  • ブラジルの使い捨て病院用品市場見通し(~2021)
    Brazil Disposable Hospital Supplies Market Outlook to 2021 Summary GlobalData’s new report, "Brazil Disposable Hospital Supplies Market Outlook to 2021", provides key market data on the Brazil Disposable Hospital Supplies market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Procedure Kits and Trays, Gloves, …
  • DIY工具の世界市場2017-2021
    About DIY Tools DIY home improvement stands as a key segment of the DIY market, and it accounts for the largest share of the global DIY market. Home improvement involves renovating or remodeling one’s home. Although the practice of DIY is quite common in the Western regions, the market is slowly picking up in the emerging regions such as APAC and MEA. In Europe, DIY is widely practiced across the …
  • 監視・セキュリティ装置の世界市場:監視装置、電子アクセスコントロールシステム、侵入防止システム、電子物品監視システム
    About Surveillance and Security Equipment Surveillance and security equipment is used for monitoring activities and behavior of individuals in areas such as airports, sea ports, railway stations, enterprises, educational institutions, retail stores, and banks that are susceptible to security threats. Proper surveillance in these areas helps reduce the occurrence of terrorist attacks and data theft …
  • 胃癌治療薬の世界市場2016-2020
    Technavio’s market research analyst predicts the global gastric cancer drugs market to grow rapidly at a CAGR of approximately 8% during the forecast period. The presence of huge unmet needs in the market is expected to result in this market’s healthy growth during the forecast period. The presence of this high-unmet medical need will lead to an increased R&D of safe and effective drugs, which in …
  • オイルフリーエアーコンプレッサーの世界市場:製品別(固定型、ポータブル型)、技術別、電力別、アプリケーション別(家電製品、製造業、エネルギー)、セグメント予測
    The global oil free air compressors market size is expected to reach USD 15.56 billion by 2025, registering a CAGR of 4.8% over the forecast period, according to a study conducted by Grand View Research, Inc. Low maintenance costs, retrofitting of existing systems, efficient operation at lower costs, and rising adoption of variable-speed compressors are some of the key factors driving the market o …
  • PrimeEnergy Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    PrimeEnergy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary PrimeEnergy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • Hidradenitis Suppurativa:グローバル臨床試験レビューH1, 2013
    Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2013" provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hidradenitis Suppurativa. It includes an overview of the trial num …
  • VoMBB通信の世界市場:VoHSPA、VoLTE
    About Global Voice over Mobile Broadband Voice over Mobile Broadband (VoMBB) is defined as end-to-end connectivity of standard cellphone calls over mobile broadband networks such as Wi-Fi, LTE, and HSPA. VoMBB provides a number of advantages to telecom carriers such as support of high quality audio, cost reduction per subscriber, improved spectral efficiency , and user terminal power savings. VoMB …
  • ベータラクタム及びベータラクタマーゼ阻害剤の世界市場:薬物クラス別、疾患別、投与経路別
    The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. Beta-lactam and beta-lactamase inhibitors is a most important type of antibacterial agent used for fighting bacterial infections. In addition, these are used to kill or prevent the growth of microorganisms. Bas …
  • エネルギー部門におけるIT支出の世界市場2016-2020:ITサービス、ソフトウェア、ハードウェア
    About IT Spending in Energy Sector IT spending comprises the spending of the enterprise on the procurement of IT solutions and services in the energy sector. Energy firms like the oil and gas companies along with the power companies require IT solutions such as on-premises of cloud-based software solutions, networking devices, equipment, and IT support services. Technavio’s analysts forecast the g …
  • バイオ肥料の世界市場:窒素固定、リン酸塩溶解
    About Biofertilizers Biofertilizers are made from human, animal, and organic wastes and are natural and sustainable in nature. Biofertilizers contain microorganisms such as bacteria, algae, and fungi alone, or in combination, which enhance nutrient availability to the plants. Benefits of biofertilizers include improved crop yields and soil fertility, and they also revive soil quality. Biofertilize …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。